New hope for stubborn elbow and foot pain? tiny particles block pain signals
NCT ID NCT06523114
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a procedure called transcatheter arterial embolization (TAE) in 12 people with long-term elbow or foot pain that didn't get better with usual treatments like physical therapy or medication. The procedure uses tiny particles to block abnormal blood vessels thought to cause pain. Researchers measured pain levels and side effects over 12 months to see if TAE is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcatheter arterial embolization (a procedure using tiny particles to block abnormal blood vessels)
What this could lead to
If it works, this could offer a new pain relief option for people with stubborn elbow or foot pain who haven't gotten help from standard treatments like physical therapy or medication.
What could go wrong
This is a very small study with only 12 people and no comparison group, so results may not apply to everyone. The procedure also carries risks like bleeding or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMBOLIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chung-Ang University Hospital
Seoul, 06973, South Korea